These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2628108)

  • 21. Affinity preparation of a protein inhibitor recognising a cell surface protease.
    Steven FS; Griffin MM; Bell J; Talbot IC
    J Enzyme Inhib; 1993; 7(1):65-76. PubMed ID: 7510796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the functional similarity between tumour cell surface guanidinobenzoatase and tissue type plasminogen activator.
    Steven FS; Griffin MM; Cederholm-Williams SA; Mangel WF; Maier H
    Anticancer Res; 1991; 11(2):641-7. PubMed ID: 1905903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protective role of a natural inhibitor in the fluorescent location of cells possessing a latent form of cell surface protease.
    Steven FS; Williams LA
    J Enzyme Inhib; 1990; 3(4):317-22. PubMed ID: 1690794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid inhibition of a tumour protease immobilised on cell surfaces and in free solution.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(1):51-9. PubMed ID: 7539069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth-related proteinase activity in a recently-established human tumour cell culture.
    Tse CA; Scott GK
    Biochem Soc Trans; 1991 Aug; 19(3):285S. PubMed ID: 1783128
    [No Abstract]   [Full Text] [Related]  

  • 26. The targeting of agmatine-liganded mitomycin C to an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1990; 10(3):583-9. PubMed ID: 2114817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protein inhibitor, extracted from Hela cells, which recognises a cell surface protease on preneoplastic cells obtained from cervical smears.
    Steven FS; Johnson J; Eason P
    Anticancer Res; 1993; 13(4):1059-61. PubMed ID: 8352525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of guanidinobenzoatase and their possible role in cell migration.
    Steven FS; Griffin MM
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():137-43. PubMed ID: 3202961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct evidence for the cell surface location of a protease-inhibitor complex on intact leukaemia cells.
    Steven FS; Griffin MM
    J Enzyme Inhib; 1990; 3(4):311-6. PubMed ID: 2319334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of fluorescent probes for an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Al-Ahmad RK
    J Chromatogr; 1986 Apr; 376():211-9. PubMed ID: 3711193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential competitive inhibition of a cell surface protease on normal epithelial cells and carcinoma cells of the colon.
    Steven FS; Anees M; Talbot IC
    Anticancer Res; 1994; 14(5A):2013-6. PubMed ID: 7847843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescent inhibitors of a cell surface protease used to locate leukaemia cells in kidney sections.
    Steven FS; Griffin MM; Wong TL; Jackson H; Barnett F
    J Enzyme Inhib; 1987; 1(3):203-13. PubMed ID: 3334245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dansyl fluoride, a fluorescent inhibitor for the location of tumour cells in human tissues.
    Anees M; Benbow EW
    J Enzyme Inhib; 1996; 10(3):195-201. PubMed ID: 8835945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the interaction and exchange of inhibitors and proteases on the surface of tumour cells in frozen sections.
    Steven FS; Griffin MM; Bulleid NJ; Maier H; Born IA
    Anticancer Res; 1991; 11(6):2117-22. PubMed ID: 1776849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of a vimentin-specific protease in mouse myeloid leukemia cells. Regulation during differentiation and identity with cathepsin G.
    Nakamura N; Tsuru A; Hirayoshi K; Nagata K
    Eur J Biochem; 1992 May; 205(3):947-54. PubMed ID: 1577012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporary competitive inhibition of a tumour cell surface protease as a protective mechanism in the preparation of the membrane bound native enzyme in the presence of excess cytoplasmic inhibitors.
    Steven FS; Griffin MM; Maier H
    J Enzyme Inhib; 1991; 5(1):77-85. PubMed ID: 1669439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of alpha 2-macroglobulin in cystic fibrosis.
    Bridges MA; Applegarth DA
    Ann N Y Acad Sci; 1983; 421():360-8. PubMed ID: 6202204
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for distinct isoenzymic forms of a cell surface protease on normal colonic cells and on carcinoma cells from the same colon.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1991; 11(1):143-50. PubMed ID: 1708219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Application to the location of cells possessing this enzyme.
    Steven FS; Griffin MM; Al-Ahmad RK
    Eur J Biochem; 1985 May; 149(1):35-40. PubMed ID: 2581779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease.
    Steven FS; Griffin MM; Williams LA; Clarke NW; Maier H
    J Enzyme Inhib; 1991; 4(4):337-46. PubMed ID: 1669833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.